<DOC>
	<DOCNO>NCT00076414</DOCNO>
	<brief_summary>This study examine anti-HIV protease inhibitor lopinavir/ritonavir ( KaletraÂ® ( Registered Trademark ) ) affect function endothelium ( line artery ) . Medications protease inhibitor dramatically change course HIV infection many patient ; however , among side effect development abnormal lipid level result high cholesterol insulin resistance . These side effect may damage line artery supply blood heart , leading premature coronary artery disease . The study determine whether lopinavir/ritonavir directly affect endothelial function whether alters cholesterol level , glucose tolerance , marker inflammation people take drug 4 week . Healthy normal volunteer 18 40 year age may eligible study . Candidates must HIV-negative history heart disease , hypertension , diabetes mellitus . They must smoke least 6 week enter study . Volunteers screen medical history , physical examination , blood test ( include pregnancy test woman childbearing potential ) , electrocardiogram . In addition , candidate oral glucose tolerance test ( see description ) . Participants undergo follow procedure : - Lopinavir/ritonavir : 4 week ( 3 capsule twice day ) begin study day 1 - Flow-mediated vasodilatation test ( study day 0 29 ) - An ultrasound device measure size brachial artery ( artery upper arm ) place elbow . The size artery measure 5 minute blood flow arm stop 5 minute , use blood pressure cuff . The artery also measure take nitroglycerin , medicine dilates blood vessel . These measurement tell well drug treatment work cell line brachial artery , indicator coronary artery function . This test take 1.5 hour . - Forearm blood-flow test ( study day 1 30 ) : Small tube insert artery vein forearm inside elbow . Blood pressure cuff place around upper arm wrist , strain gauge ( rubber band-like device ) place around forearm . When blood pressure cuff inflate , blood flow forearm , stretch strain gauge rate proportional blood flow . When device place , salt water solution inject small tube artery . After 20 minute , small dos follow drug give catheter various interval : 1 ) L-NMMA ( block production nitric oxide , substance produce blood vessel cause dilate ) ; 2 ) sodium nitroprusside ( dilate blood vessel , increase blood flow ) ; 3 ) acetylcholine ( lower blood pressure ) ; 4 ) acetylcholine plus L-NMMA . The effect different drug blood flow forearm measure . The study take 2 hour complete . - Blood test ( screen study day 1,15 , 30 , 44 ) - Electrocardiogram ( screen study day 30 ) - Oral glucose tolerance test ( screen study day 30 ) - A blood sample collect . Then , subject drink 300 milliliter glucose solution ( liquid contain sugar dissolved water ) . Two hour drink solution , blood drawn examine body respond increase blood sugar level .</brief_summary>
	<brief_title>The Effect Lopinavir/Ritonavir Endothelial Function</brief_title>
	<detailed_description>With advent highly active antiretroviral ( ARV ) therapy era , patient human immunodeficiency virus ( HIV ) significantly decrease mortality morbidity . Concomitant patient chronically take antiretroviral therapy , increase atherogenic lipoprotein profile ( high cholesterol , high triglyceride , low HDL 's ) , insulin resistance , fat redistribution coronary artery disease . HIV viral replication , anti-retroviral treatment regimen , lipid , glucose intolerance , host immune response combination factor may contribute increase cardiovascular risk factor . HIV positive patient , independent effect lipid , appear increase cardiovascular risk . Studies entirely consistent , convince study date , D.A.D . study EURO-SIDA , show 27 % relative increase rate myocardial infarction per year exposure first seven year ART . Lopinavir-ritonavir one commonly use antiretroviral therapy . It also produce lipid abnormality . Thus , important part investigate factor contribute atherosclerosis would determine drug adversely influence endothelial cell absence HIV infection low CD4 count . This would suggest drug directly indirectly could predispose atherosclerosis . Endothelial function important contributor atherosclerosis . Invasive non-invasive method evaluate endothelial cell function validate predictor coronary artery disease . These technique use NIH clinical investigation many year . This protocol design determine whether pathologic effect endothelial function lopinavir/ritonavir . By measure endothelial function HIV non-infected subject four week therapy , able investigate whether medication direct toxic effect endothelium . Collection metabolic data allow u evaluate whether endothelial function occur conjunction separate lipoprotein glucose metabolic change . As ARV option increase , may possible choose specific regimen may minimize acceleration cardiovascular risk factor associate endothelial dysfunction , especially patient cardiovascular risk factor . These finding may help elucidate pathophysiology premature cardiovascular disease HIV positive patient also plan intervention minimize endothelial dysfunction subsequent cardiovascular disease .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Acetylcholine</mesh_term>
	<criteria>INCLUSION CRITERIA : Age 1840 . Healthy medical history physical examination . Negative serum pregnancy test female . Females willing use two form birth control include barrier contraception period study ( lopinavir/ritonavir decrease ethinyl estradiol level ) . Able provide inform consent . Laboratory value screen visit within : AST le 40 units/liter , serum creatinine le 1.5mg/dl ; CPK le 387 , hemoglobin great 11.0 g/dL ( female ) great 12.6 g/dL ( male ) , platelets great 154,000/mm ( 3 ) , total bilirubin less equal 1.5 mg/d Total cholesterol le 200 mg/dL , LDL cholesterol le 160 mg/dL , HDL cholesterol great 30mg/dL , triglyceride le 200 mg/dL . Nonsmoker smoke past 6 week . Negative HIV ELISA within 4 week study participation . EXCLUSION CRITERIA : Concomitant therapy prescription , overthecounter alternative medication except intermittent use acetaminophen , nonsteroidal antiinflammatory medication , loperamide oral contraceptive . Inability obtain venous access sample collection . Presence diabetes mellitus fast blood sugar great 126 mg/dL , abnormal oral glucose tolerance test ( 2 hour post blood sugar great 200 mg/dL ) . Human immunodeficiency virus ( HIV ) infection . Cardiac disease , congestive heart disease , coronary artery disease , angina , carotid stenosis , peripheral vascular disease , cerebrovascular disease , myocardial disease , clinically significant valvular heart disease . Any condition may interfere interpretation study result best interest subject opinion investigator . Hypertension ( systolic blood pressure great 140 mmHg diastolic blood pressure great 90 mmHg ) screen visit . Observed abnormalities EKG tracing significant opinion investigator ( example include , AV block , multifocal atrial tachycardia , frequent premature ventricular contraction , etc. ) . Hypotension ( systolic blood pressure le 80 mmHG ) . Pregnant breastfeed female . Inability abstain caffeine use ( coffee , tea soda ) alcohol 12 hour prior blood flow study conclusion study . Heavy alcohol ingestion ( 4 drink day ) current substance abuse . Hypo hyper thyroidism . Allergy lidocaine . History hepatitis liver disease .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Endothelial Function</keyword>
	<keyword>Lopinavir/Ritonavir</keyword>
	<keyword>HIV</keyword>
	<keyword>Blood Flow Studies</keyword>
	<keyword>Flow-Mediated Vasodilatation</keyword>
	<keyword>Healthy Volunteer</keyword>
	<keyword>HV</keyword>
</DOC>